Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20100407003647N2
IRCT20100407003647N2
Completed
未知

Evaluation of the therapeutic effects of using peripheral blood stem cells in spinal fusion in patients with thoracolumbar fractures

Mashhad University of Medical Sciences0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
30
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •age 20\-60 years
  • •spine surgery is needed

Exclusion Criteria

  • •HIV\+,HBV\+,HCV\+
  • •Probability of patient not following
  • •Previous bone malignancy
  • •Pelvic fracture
  • •Background illnesses including osteoporosis
  • •Taking steroids

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Evaluation of the therapeutic effects of Iranian Traditional Medicine (Hab Shabyar) in patients with open-angle glaucoma: A double-blind clinical trialopen-angle glaucoma.Primary open-angle glaucoma
IRCT2016052828127N1Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences50
Recruiting
Phase 1
Clinical and translational controlled study of Perampanel treatment around Surgery in patients with progressive glioblastoma (PerSurge)Progressive GlioblastomaMedDRA version: 20.0Level: PTClassification code: 10018336Term: Glioblastoma Class: 100000004864Therapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2023-503938-52-00niversitaetsklinikum Heidelberg AöR66
Recruiting
Phase 2
A Phase II study of the Perflubutane for predicting TILs in EBC (AppTIL study)Early Breast Cancer (cStage I-IIIA)Breast Cancer, TIL, Tumor Infiltrating Lymphocyte, LPBC, Contrast-enhanced ultrasonography, US, Perflubutane, Sonazoid
JPRN-jRCT1061220081Shigematsu Hideo100
Recruiting
Phase 2
A Phase II study of the efficacy and safety of Perflubutane for predicting highly Tumor Infiltrating Lymphocytes in early breast cancer (AppTIL study)
JPRN-UMIN000050067Hiroshima University Hospital100
Completed
Phase 3
Effect of probiotic supplements on children's asthmaAsthma.Asthma
IRCT20180115038378N1Sabzevar University of Medical Sciences120